Novavax trial reveals 89.3% effectiveness in preventing COVID-19
Interim analysis of study shows that the NIHR-supported Novavax COVID-19 vaccine is 89.3% effective at preventing COVID-19, including effectiveness against the new variants of concern.
By King's CRF at 29 Jan 2021